Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $132.60 | Total: $663.00 |
| 1 | 10 | $112.32 | Total: $1,123.20 |
| 1 | 25 | $95.16 | Total: $2,379.00 |
| 1 | 50 | $81.12 | Total: $4,056.00 |
| 1 | 100 | $70.20 | Total: $7,020.00 |
Overview
BAY-2402234 is an inhibitor of dihydroorotate dehydrogenase (DHODH) for the treatment of myeloid malignancies.BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity.
Chemical Properties
| Molecular Formula | C21H18ClF5N4O4 |
| Molecular Weight | 520.84 |
| CAS Numbers | 2225819-06-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCn1c(CO)nn(-c2cc(O[C@@H](C)C(F)(F)F)c(cc2F)C(=O)Nc2c(F)cccc2Cl)c1=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Andreas Janzer, et al. Abstract DDT02-04 BAY 2402234 A novel, selective dihydroorotate dehydrogenase [DHODH] inhibitor for the treatment of myeloid malignancies. AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL.